Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Pharmagene describes furan-based prostanoid EP4 antagonist for migraine therapy

Sep. 15, 2004

New PKC-theta inhibitors and their use covered by Boehringer Ingelheim patent

Sep. 15, 2004

Sandoz presents new beta-lactam antibiotic prodrugs

Sep. 15, 2004

Ranbaxy researchers present novel muscarinic antagonists

Sep. 15, 2004

Novel HDAC inhibitors prepared and tested at Oxford GlycoSciences

Sep. 15, 2004

New alpha2C-adrenoceptor antagonists identified at Juvantia

Sep. 15, 2004

Novel VAP-1 inhibitors and their use in macular edema described by Fujisawa

Sep. 15, 2004

New PYY analogues and their use in body weight disorders

Sep. 14, 2004

Novel 11beta-HSD-1 inhibitors in early development at Novartis

Sep. 14, 2004

New alpha2, alpha3 and/or alpha5-selective GABA-A receptor ligands claimed by Merck

Sep. 14, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...